Welcome to sterna biologicals

sterna biologicals GmbH & Co. KG, a spin-off from Marburg University (Germany), is an innovative biopharmaceutical company developing novel treatments for chronic inflammatory diseases of lung and skin such as asthma, atopic dermatitis, ulcerative colitis, psoriasis, and COPD. By targeting transcription factors that play a pivotal role in regulating underlying inflammatory mechanisms, the company's next generation antisense molecules (DNAzymes) intervene at a very early stage in the disease formation process.